Nanobiotix
IPOBuilding new cancer therapies atom by atom | Nanobiotix
Public · Paris, France · $14.6M raised
- Headquarters
- Paris
- Employees
- 51–200
- Business Model
- B2B
- Website
- nanobiotix.com
- Total Funding
- $14.6M
- Last Round
- $4.8M Corporate RoundDec 2023
- Rounds
- 3
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 7 funding rounds and 2 investors for this company. The full record is or through the API.
About
French clinical-stage nanotech company developing hafnium oxide nanoparticle NBTXR3 to amplify radiotherapy effects in cancer tumors.
Summary
Nanobiotix is a Biotech company based in Paris, France. It has raised $14.6M in total across 3 rounds, most recently a $4.8M Corporate Round in Dec 2023. Investors include Healthcare Royalty Partners and Johnson & Johnson Innovation.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Oct 2025
Sign up to see all 7 events
Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nanobiotix-s-a"><img src="https://indexed.vc/api/badge/company/nanobiotix-s-a" alt="Nanobiotix on Indexed.vc" width="260" height="76" /></a>